FEDERAL CIRCUIT AND FAMILY COURT OF AUSTRALIA
(DIVISION 2)
iNova Pharmaceuticals (Australia) Pty Ltd v Letos Group Pty Ltd (No 3) [2023] FedCFamC2G 801
File number(s): SYG 3343 of 2019 Judgment of: JUDGE MANOUSARIDIS Date of judgment: 1 September 2023 Catchwords: INTELLECTUAL PROPERTY – Practice and procedure – orders for summary judgment and judgment by default had been made and entered subject to further submissions on the assessment of compensation, interest, and costs – orders made for compensation, interest, and costs. Legislation: Competition and Consumer Act 2010 (Cth) Sch 2, s 236
Copyright Act 1968 (Cth) s 115(2)
Federal Circuit and Family Court of Australia Act 2021 (Cth) s 212
Trade Marks Act 1995 (Cth) ss 126(1)(b), 126(2)
Federal Circuit and Family Court of Australia (Division 2) (General Federal Law) Rules 2021 (Cth) r 22.02(2)
Cases cited: A2B Australia Limited v Verma [2021] FedCFamC2G 204
iNova Pharmaceuticals (Australia) Pty Ltd v Letos Group Pty Ltd [2022] FedCFamC2G 1052
Division: General Number of paragraphs: 20 Date of last submission/s: 5 May 2023 Date of hearing: 1 March 2023 Place: Sydney Counsel for the Applicants: Ms F St John Solicitor for the Applicants: Gilbert + Tobin The Fifteenth, Sixteenth, and Twentieth Respondents: Appeared in person, with the assistance of an interpreter The Fourth, Fifth, Sixth, Seventh, Eleventh, Twelfth, Thirteenth, and Fourteenth Respondents: No appearance by, or on behalf of, the Fourth, Fifth, Sixth, Seventh, Eleventh, Twelfth, Thirteenth and Fourteenth Respondents ORDERS
SYG 3343 of 2019 FEDERAL CIRCUIT AND FAMILY COURT OF AUSTRALIA (DIVISION 2)
BETWEEN: INOVA PHARMACEUTICALS (AUSTRALIA) PTY LTD ACN 617 871 539
First Applicant
INOVA PHARMACEUTICALS (SINGAPORE) PTE. LIMITED UEN 200617543H
Second Applicant
AND: LETOS GROUP PTY LTD ACN 623 106 561
Fourth Respondent
LIYAN LIANG
Fifth Respondent
C&J AUS GROUP PTY LTD ACN 617 599 961 (and others named in the Schedule)
Sixth Respondent
ORDER MADE BY:
JUDGE MANOUSARIDIS
DATE OF ORDER:
1 SEPTEMBER 2023
THE COURT ORDERS THAT:
1.Pursuant to s 236 of Schedule 2 to the Competition and Consumer Act 2010 (Cth), s 126(1)(b) of the Trade Marks Act 1995 (Cth) (Trade Marks Act), and s 115(2) of the Copyright Act 1968 (Cth) (Copyright Act):
(a)the fourth respondent (Letos Group Pty Ltd) and the fifth respondent (Liyan Liang) pay:
(i)$46,798.20 to the first applicant (iNova Australia); and
(ii)$79,380.35 to the second applicant (iNova Singapore);
(b)the sixth respondent (C & J Aus Group Pty Ltd) and the seventh respondent (Taiyi Chang) pay:
(i)$11,971.60 to iNova Australia; and
(ii)$20,323.30 to iNova Singapore; and
(c)eleventh respondent (Jun Wei Pty Ltd), the twelfth respondent (Ningning Wei), and the thirteenth respondent (Li Bin) pay:
(i)$58,305.24 to iNova Australia; and
(ii)$98,888.87 to iNova Singapore.
2.Pursuant to s 126(2) of the Trade Marks Act:
(a)the fourth respondent (Letos Group Pty Ltd) and the fifth respondent (Liyan Liang) pay:
(i)$23,399.10 to the iNova Australia, being 50% of the amount specified in order 1(a)(i); and
(ii)$39,690.17 to the iNova Singapore, being 50% of the amount specified in order…
Keep reading for free
Create a free CaseChat account to read iNova Pharmaceuticals (Australia) Pty Ltd v Letos Group Pty... and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2023] FedCFamC2G 801
- Decision Date
CaseChat Overview and Summary
The court found that the applicants' evidence, particularly the affidavits of Mr. Sachin Roneal Deo, Ms. Sally Louise Davitt, and Ms. Kate Messiter, adequately demonstrated the impact of the respondents' infringing conduct on the applicants' profits. The court accepted the applicants' calculations of damages, interest, and costs, which were based on the report prepared by Ms. Davitt and the affidavit of Mr. Michael John Williams. The court made orders for compensation, additional damages, and interest for the amounts claimed by the applicants against the remaining respondents. The court also made lump sum costs orders against the remaining respondents based on the applicants' submissions and the principles stated in A2B Australia Limited v Verma.
The court's decision in iNova Pharmaceuticals (Australia) Pty Ltd v Letos Group Pty Ltd (No 3) involved the assessment of compensation, interest, and costs in a trademark and copyright infringement case. The court found that the applicants' evidence was sufficient to support their claims for damages, interest, and costs against the remaining respondents. The court accepted the applicants' calculations of these amounts and made orders accordingly. The decision demonstrates the court's consideration of the principles and factors involved in assessing compensation, interest, and costs in intellectual property cases.
Orders
Orders of the court
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi